Nuvectis Pharma, Inc. Shareholders' Equity
Nuvectis Pharma, Inc. (NVCT) had Shareholders' Equity of $9.08 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-04
- 2026-06-30: Stockholders' Equity Attributable to Parent $9.08M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $14.22M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $18.41M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $24.01M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $9.08M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $14.22M 10-Q · filed 2026-08-04 |
| 2025-12-31 | $18.41M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $24.01M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $16.87M 10-Q · filed 2026-08-04 |
| 2025-03-31 | $20.95M 10-Q · filed 2026-08-04 |
| 2024-12-31 | $9.71M 10-Q · filed 2026-08-04 |
| 2024-09-30 | $10.99M 10-Q · filed 2025-11-04 |
| 2024-06-30 | $12.53M 10-Q · filed 2025-11-04 |
| 2024-03-31 | $14.02M 10-Q · filed 2025-11-04 |
| 2023-12-31 | $12.20M 10-K · filed 2026-02-11 |
| 2023-09-30 | $16.69M 10-Q · filed 2024-11-05 |
| 2023-06-30 | $20.33M 10-Q · filed 2024-11-05 |
| 2023-03-31 | $12.27M 10-Q · filed 2024-11-05 |
| 2022-12-31 | $14.22M 10-K · filed 2025-02-25 |
| 2022-09-30 | $20.37M 10-Q · filed 2023-11-08 |
| 2022-06-30 | $11.50M 10-Q · filed 2023-11-08 |
| 2022-03-31 | $14.56M 10-Q · filed 2023-11-08 |
| 2021-12-31 | -$11.01M 10-K · filed 2024-03-05 |
| 2021-09-30 | -$8.93M 10-Q · filed 2022-11-08 |
| 2021-06-30 | -$4.40M 10-Q · filed 2022-11-08 |
| 2021-03-31 | -$33.00K 10-Q · filed 2022-11-08 |
| 2020-12-31 | -$10.00K 10-K · filed 2023-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |